Male, 52
GLP-1 telehealth, 6 months
Reported -28 lbs over 6 months of compounded GLP-1 telehealth treatment. User-shared, identifiers blurred.
-28 lbs6 monthsUser-shared
Real GLP-1 before-and-after results
What outcomes does the clinical research actually show?
Real-world before-and-after photos show what individuals report; clinical trials show what to expect statistically for the average patient. Here's the gap:
| Medication / Trial | Mean weight change | Duration | Achieved ≥10% WL |
|---|---|---|---|
| Semaglutide 2.4 mg — STEP-1 (NEJM 2021) | -14.9% | 68 weeks | 69.1% |
| Tirzepatide 15 mg — SURMOUNT-1 (NEJM 2022) | -20.9% | 72 weeks | 90.0% |
| Retatrutide 12 mg — TRIUMPH-1 (NEJM 2026) | -28.3% | 80 weeks | ~94% |
| Placebo + lifestyle | -2.4% | 68 weeks | 12.0% |
Compounded semaglutide and tirzepatide use the same active ingredients as the FDA-approved brands, but compounded products are not FDA-approved and real-world outcomes may vary from brand trial data due to differences in excipients, concentration, and dose calibration.
How outcomes compare across the three GLP-1 generations
Considering a GLP-1 program?
Our current Editor's Pick is NexLife for both compounded semaglutide and tirzepatide — flat-rate pricing from $119/mo (sema) and $139/mo (tirz) on the 12-month plan, MD/DO oversight under Dr. Adam Kennah, three pharmacies named on its plan pages, Care360 coaching included (lab work not stated), all 50 states. NexLife says it serves all 50 states where its affiliated providers are licensed (it does not publish patient counts) through the program.
Check NexLife Semaglutide → Check NexLife Tirzepatide →Want to see the comparisons across all major providers?
The full apples-to-apples comparison covers 8 providers across price, pharmacy transparency, clinical model, and "best for" categories: Compounded GLP-1 telehealth comparison →
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
TRUE AFFORDABILITY HUB
Compare GLP-1 pricing the right way
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.
Most Affordable Compounded Tirzepatide Online True monthly cost vs teaser pricing →
Most Affordable Compounded Semaglutide Online True monthly cost vs teaser pricing →
Teaser Pricing vs Transparent GLP-1 Pricing How to spot hidden fees →
Flat-Rate GLP-1 Providers Dose-independent pricing model →
NexLife Review 94/100 transparency rubric →
NexLife Care360 Included coaching deep dive →
★ THIRD-PARTY CORROBORATION
Verify us yourself
We do not invent reviews and we do not stage patient testimonials. Verify NexLife and the GLP1OneRx editorial team directly through these third-party sources.
LegitScript ↗
Healthcare Merchant Certified
Verify NexLife on the official LegitScript database
Trustpilot ↗
Real patient reviews
Independent reviews from verified NexLife patients
Better Business Bureau ↗
Business accreditation
Verify NexLife's business standing
Google Search ↗
Independent search results
See what the open web says about NexLife
NexLife official ↗
Direct site & contact
Verify pricing, FAQs, and team page directly
Corporate registry ↗
Delaware C-Corp filing
Verify NexLife Inc. on OpenCorporates
Our policy on reviews and testimonials
GLP1OneRx is editorial. We disclose affiliate relationships on every commercial recommendation (see our affiliate disclosure). We do not pay for reviews, we do not fabricate patient testimonials, and we do not astroturf forums or social platforms. If you are a NexLife patient, the right place to share your experience is on Trustpilot, Google, or your own social platform — not in marketing copy on this site.
Questions readers ask
How much weight did the people in these before-and-after photos report losing?
The four user-shared photos report losses from −22 lbs over 5 months to −72 lbs over 12 months of compounded GLP-1 telehealth treatment. They are illustrative, identifiers are blurred, and individual results vary.
Are these photos testimonials from NexLife patients?
No. The page says the photos were shared publicly by users online and are not NexLife or any single provider’s customer testimonials. They illustrate outcomes patients have reported, not promised results.
Why might compounded GLP-1 results differ from brand-name trial data?
Compounded semaglutide and tirzepatide are not FDA-approved, and real-world outcomes may differ from brand trials because of differences in excipients, concentration and dose calibration. Trial averages were −14.9% for semaglutide 2.4 mg at 68 weeks and −20.9% for tirzepatide 15 mg at 72 weeks.
What does the site’s top-rated program charge for compounded GLP-1s?
NexLife, rated 94/100, charges $119 a month for semaglutide and $139 for tirzepatide on a 12-month plan, same price at every dose (read October 14, 2026). It is not the lowest month-to-month price: Collective lists $59 and $69 plus a $199 yearly membership.
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Registered outsourcing facilities (503B)
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
- Wegovy (semaglutide) prescribing information, Novo Nordisk